AIDS vaccine: Efficacy, safety and ethics
MetadataShow full item record
Human immunodeficiency virus (HIV) has infected 50 million people worldwide and killed 16 million so far, and the epidemic is still spreading with 16,000 new cases of HIV infection daily and a projection of 100million infected individuals by the end of the next decade. There is no question that a safe and effective acquired immunodeficiency syndrome (AIDS) vaccine is urgently needed to bring the current AIDS pandemic under control. But, is preventive AIDS vaccine an attainable goat? Unfortunately, the results of many laboratory and clinical studies over the past two decades are not encouraging. We comment on the efficacy, safety and ethics of AIDS vaccine, and the urgent need for a new strategy for AIDS vaccine development. (c) 2007 Elsevier Ltd. All. rights reserved.
Keywords:AIDS vaccine / safety / efficacy
Source:Vaccine, 2008, 26, 24, 3072-3077
- 1st International Symposium on Genetic and Immune Correlates of HIV Infection and Vaccine-Induced Immunity, Jun 10-13, 2007, Budapest, Hungary